Kite to Present at March 2017 Investor Conferences

SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc. (Nasdaq: KITE) today announced that management will present at two investor conferences in March 2017:

A live audio webcast of each event will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of each webcast will be available on the website for approximately 30 days.

About Kite

Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170306005463/en/

Kite Pharma, Inc.
Christine Cassiano
SVP, Corporate Communications & Investor Relations
[email protected]
or
Greg Mann
VP, Investor Relations
[email protected]

Source: Kite Pharma, Inc.

You May Also Be Interested In

• CSX (CSX) PT Raised to $46 at TD Cowen
• Building Against the Attention Economy: Mohammed Abdul Kamran Brings His Privacy-First Vision to Faith Technology
• AlgoLaser Launches DIY KIT MK3: Start, Just That Simple--A Smarter Way to Laser Engrave